{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:09:30Z","timestamp":1792177770593,"version":"4.4.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.sleep.2019.05.002","type":"journal-article","created":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T11:46:36Z","timestamp":1557488796000},"page":"19-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["The efficacy and safety of rotigotine transdermal patch for the treatment of sleep disorders in Parkinson's disease: a meta-analysis"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3441-9400","authenticated-orcid":false,"given":"Lu","family":"Fei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Tong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"S17","key":"10.1016\/j.sleep.2019.05.002_bib1","doi-asserted-by":"crossref","first-page":"S367","DOI":"10.1002\/mds.21682","article-title":"Sleep disorders in Parkinson's disease: an overview","volume":"22","author":"Comella","year":"2010","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.sleep.2019.05.002_bib2","first-page":"5","article-title":"Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study","volume":"257","author":"Colosimo","year":"2010","journal-title":"J\u00a0Neurol"},{"issue":"6","key":"10.1016\/j.sleep.2019.05.002_bib3","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.clineuro.2012.07.032","article-title":"Prevalence of non motor features in a cohort of Parkinson's disease patients","volume":"115","author":"Khedr","year":"2013","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.sleep.2019.05.002_bib4","article-title":"A\u00a0systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease from 2005\u20132015","volume":"35","author":"Chahine","year":"2016","journal-title":"Sleep Med Rev"},{"issue":"1","key":"10.1016\/j.sleep.2019.05.002_bib5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00210-008-0341-4","article-title":"The in\u00a0vitro receptor profile of rotigotine: a new agent for the treatment of Parkinson's disease","volume":"379","author":"Scheller","year":"2009","journal-title":"N\u00a0Schmied Arch Pharmacol"},{"key":"10.1016\/j.sleep.2019.05.002_bib6","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1001\/archneur.60.12.1721","article-title":"A\u00a0controlled trial of rotigotine monotherapy in early Parkinson's disease","volume":"60","author":"Parkinson Study Group","year":"2003","journal-title":"Arch Neurol"},{"issue":"4","key":"10.1016\/j.sleep.2019.05.002_bib7","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/mds.26528","article-title":"Effect of levodopa-carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients","volume":"31","author":"Antonini","year":"2016","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"10.1016\/j.sleep.2019.05.002_bib8","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1212\/01.wnl.0000252355.79284.22","article-title":"Randomized, blind, controlled trial of transdermal rotigotine in early Parkinson disease","volume":"68","author":"Watts","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2019.05.002_bib9","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1002\/mds.21741","article-title":"Rotigotine transdermal patch in early Parkinson's disease: a randomized, double-blind, controlled study versus placebo and ropinirole","volume":"22","author":"Giladi","year":"2007","journal-title":"Mov Disord"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.sleep.2019.05.002_bib10","first-page":"S66","article-title":"For the SP511 Investigators. Rotigotine transdermal delivery system (TDS) (SPM 962): a multicenter, double-blind, randomized, placebo-controlled trial to assess the safety and efficacy of rotigotine TDS patients with advanced Parkinson's disease","volume":"7","author":"Quinn","year":"2001","journal-title":"Park Relat Disord"},{"issue":"6","key":"10.1016\/j.sleep.2019.05.002_bib11","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S1474-4422(07)70108-4","article-title":"Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial","volume":"6","author":"Poewe","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.sleep.2019.05.002_bib12","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1212\/01.wnl.0000259516.61938.bb","article-title":"Advanced Parkinson disease treated with rotigotine transdermal system: PREFER study","volume":"68","author":"LeWitt","year":"2007","journal-title":"Neurology"},{"issue":"7829","key":"10.1016\/j.sleep.2019.05.002_bib13","first-page":"889","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ Br Med J"},{"key":"10.1016\/j.sleep.2019.05.002_bib14","series-title":"Rotigotine for nocturnal hypokinesia in Parkinson s disease Quantitative analysis of efficacy from a randomized, placebo-controlled trial using an axial inertial sensor","author":"Bhidayasiri","year":"2017"},{"key":"10.1016\/j.sleep.2019.05.002_bib15","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.sleep.2016.01.016","article-title":"Rotigotine may improve sleep architecture in Parkinson's disease: a double-blind, randomized, placebo-controlled polysomnographic study","volume":"21","author":"Pierantozzi","year":"2016","journal-title":"Sleep Med"},{"issue":"1","key":"10.1016\/j.sleep.2019.05.002_bib16","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/mds.23441","article-title":"Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER)","volume":"26","author":"Trenkwalder","year":"2015","journal-title":"Mov Disord"},{"issue":"12","key":"10.1016\/j.sleep.2019.05.002_bib17","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.parkreldis.2014.10.005","article-title":"Rotigotine vs ropinirole in advanced stage Parkinson's disease: a double-blind study","volume":"20","author":"Mizuno","year":"2014","journal-title":"Park Relat Disord"},{"issue":"3\u20134","key":"10.1016\/j.sleep.2019.05.002_bib18","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000355019","article-title":"Associations between severity\u00a0of motor function and nonmotor symptoms in Parkinson's disease: a post hoc analysis of the RECOVER Study","volume":"71","author":"Swick","year":"2014","journal-title":"Eur Neurol"},{"issue":"1","key":"10.1016\/j.sleep.2019.05.002_bib19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12883-016-0610-7","article-title":"Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson's disease","volume":"16","author":"Hauser","year":"2016","journal-title":"BMC Neurol"},{"issue":"10","key":"10.1016\/j.sleep.2019.05.002_bib20","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1111\/ene.12757","article-title":"Effects of rotigotine transdermal patch in patients with Parkinson's disease presenting with non-motor symptoms - results of a double-blind, randomized, placebo-controlled trial","volume":"22","author":"Antonini","year":"2015","journal-title":"Eur J Neurol"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945719301406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945719301406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T15:14:21Z","timestamp":1761405261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945719301406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":20,"alternative-id":["S1389945719301406"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2019.05.002","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy and safety of rotigotine transdermal patch for the treatment of sleep disorders in Parkinson's disease: a meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2019.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}